vTv Therapeutics is a late-stage biopharmaceutical company dedicated to developing innovative oral drug candidates aimed at treating diabetes and other chronic diseases. With a strong focus on its lead product, cadisegliatin, currently in Phase 3 trials for type 1 diabetes, vTv is pushing the boundaries of what's possible in chronic disease management through a diverse clinical pipeline.
No jobs found
Try different keywords or remove some filters.
Or create a free account and we’ll email you when new jobs match what you’re looking for.
Create a free account
Searching